N. Amin

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

P. Raggi, G. Chertow, S. Chasan-Taber, 2002, Journal of the American College of Cardiology.

Sevelamer Hydrochloride (Renagel®), a Nonabsorbed Phosphate‐Binding Polymer, Does Not Interfere with Digoxin or Warfarin Pharmacokinetics

Carlo Incerti, M. Plone, N. Watson, 2001, Journal of clinical pharmacology.

The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure.

N. Amin, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection.

Z. Varghese, D. Wheeler, D. Mikhailidis, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Assigning severity indices to outcomes

N. Amin, 1999 .

Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.

G. Chertow, S. Burke, N. Amin, 2000, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects

C. O. Kamlin, K. Weiss, P. Dogterom, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

End-Stage Renal Disease Cardiac Calcification in Adult Hemodialysis Patients

G. Chertow, S. Chasan-Taber, S. Burke, 2016 .

Sevelamer Hydrochloride (Renagel®), a Phosphate‐Binding Polymer, Does Not Alter the Pharmacokinetics of Two Commonly Used Antihypertensives in Healthy Volunteers

Carlo Incerti, M. Plone, S. Burke, 2001, Journal of clinical pharmacology.